Sounds good but it's 3 million out of QBL/MCL coughers for this research over 3 years, we need to be bringing in some serious revenue if we are potentially going to fund this & also the first million for Canntab should it be realized here in Australia & Asia.
Looking forward to seeing some revenue figures or announcements that are going to raise revenue in the short to medium term, I agree its critical to invest in the future but the books need to reflect our capacity to do so, don't want to extend ourselves beyond means.
I got a good feeling sales are going to be strong though! I have faith in QBL & Andrew to make the right calls.
- Forums
- ASX - By Stock
- CGB
- Ann: A World First for MCL in Autoimmune Disease Reasearch
Ann: A World First for MCL in Autoimmune Disease Reasearch, page-5
-
- There are more pages in this discussion • 274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online